Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SBRT for oligoprogressive oncogene addicted NSCLC.
Basler L, Kroeze SG, Guckenberger M. Basler L, et al. Lung Cancer. 2017 Apr;106:50-57. doi: 10.1016/j.lungcan.2017.02.007. Epub 2017 Feb 6. Lung Cancer. 2017. PMID: 28285694 Review.
Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition.
Basler L, Gabryś HS, Hogan SA, Pavic M, Bogowicz M, Vuong D, Tanadini-Lang S, Förster R, Kudura K, Huellner MW, Dummer R, Guckenberger M, Levesque MP. Basler L, et al. Clin Cancer Res. 2020 Aug 15;26(16):4414-4425. doi: 10.1158/1078-0432.CCR-20-0020. Epub 2020 Apr 6. Clin Cancer Res. 2020. PMID: 32253232 Free article.
Targeting Treatment Resistance in Head and Neck Squamous Cell Carcinoma - Proof of Concept for CT Radiomics-Based Identification of Resistant Sub-Volumes.
Bogowicz M, Pavic M, Riesterer O, Finazzi T, Garcia Schüler H, Holz-Sapra E, Rudofsky L, Basler L, Spaniol M, Ambrusch A, Hüllner M, Guckenberger M, Tanadini-Lang S. Bogowicz M, et al. Among authors: basler l. Front Oncol. 2021 May 27;11:664304. doi: 10.3389/fonc.2021.664304. eCollection 2021. Front Oncol. 2021. PMID: 34123824 Free PMC article.
Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint Inhibition.
Burgermeister S, Gabryś HS, Basler L, Hogan SA, Pavic M, Bogowicz M, Martínez Gómez JM, Vuong D, Tanadini-Lang S, Foerster R, Huellner MW, Dummer R, Levesque MP, Guckenberger M. Burgermeister S, et al. Among authors: basler l. Front Oncol. 2022 Apr 14;12:830627. doi: 10.3389/fonc.2022.830627. eCollection 2022. Front Oncol. 2022. PMID: 35494048 Free PMC article.
PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors.
Gabryś HS, Basler L, Burgermeister S, Hogan S, Ahmadsei M, Pavic M, Bogowicz M, Vuong D, Tanadini-Lang S, Förster R, Kudura K, Huellner M, Dummer R, Levesque MP, Guckenberger M. Gabryś HS, et al. Among authors: basler l. Front Oncol. 2022 Nov 24;12:977822. doi: 10.3389/fonc.2022.977822. eCollection 2022. Front Oncol. 2022. PMID: 36505821 Free PMC article.
Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging.
Oliveira C, Amstutz F, Vuong D, Bogowicz M, Hüllner M, Foerster R, Basler L, Schröder C, Eboulet EI, Pless M, Thierstein S, Peters S, Hillinger S, Tanadini-Lang S, Guckenberger M. Oliveira C, et al. Among authors: basler l. EJNMMI Res. 2021 Aug 21;11(1):79. doi: 10.1186/s13550-021-00809-3. EJNMMI Res. 2021. PMID: 34417899 Free PMC article.
29 results